OTC医薬品・栄養補助食品市場レポート：2022-2032

OTC Drugs & Dietary Supplements Market Report 2022-2032

レポート詳細 OTC医薬品・栄養補助食品市場レポート 2022-2032 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2022年10月11日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	400	391	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

OTC医薬品・栄養補助食品市場レポート 2022-2032:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

市場成長を牽引するセルフケア
新興国や先進国において、人々は健康、フィットネス、ウェルネスプログラムに意識を向けるようになり、この傾向は世界的に拡大しています。予防接種やワクチン接種、子どもの死亡率低下や子どもの免疫力向上のための予防措置、多くの国における生活水準の向上、栄養補助食品などは、人々の寿命を延ばすために世界的に取り入れられている主要な取り組みです。

セルフケアとは、医師の手を借りずに自己診断で病気を治すことです。体の痛み、発熱、咳、風邪、アレルギー、ニキビなどのスキンケア、口腔や歯の衛生、消化不良や酸欠などの胃腸障害など、いずれもセルフケアですぐに対処することができます。セルフケアの範囲は時代とともに拡大し、現在ではプライマリーケアにとどまらず、健康増進や病気のリスクを軽減することも含まれるようになっています。

市場成長を促進すると予想される食生活に関するキャンペーンの重要性
公衆衛生機関、執行機関、協会、業界、その他の団体は、品質の高いサプリメントを選ぶためのアドバイスを提供し、身元や品質が保証されていない商品の潜在的リスクについて説明する教育プログラムに投資する必要がある。消費者は、第三者による独立した検証手順が、製品や成分の表示を立証するのに役立つことを認識すべきである。感化キャンペーンは、消費者層（高齢者、妊婦、軍人など）において、低品質の食品がもたらす生理的影響に最も敏感である、あるいは予測されるものに焦点を絞るべきであります。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- OTC医薬品・栄養補助食品市場はどのように進化しているのか？
- OTC医薬品・栄養補助食品市場を牽引・抑制しているものは何か？
- OTC医薬品・栄養補助食品の各サブマーケットセグメントは予測期間中にどのように成長し、2032年にはどれくらいの売上を占めるようになるのでしょうか？
- 2022年から2032年にかけて、各OCTC医薬品・栄養補助食品サブマーケットの市場シェアはどのように推移するのでしょうか？
- 2022年から2032年にかけて、市場全体の主な牽引役は何になるのか？
- OTC医薬品・栄養補助食品の主要市場はマクロ経済の動きに概ね追随するのか、それとも個々の国市場が他を凌駕するのか？
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年に市場をリードするのか？
- 主要プレイヤーは誰か、また予測期間中の見込みは？
- これらの主要企業のOTC医薬品・栄養補助食品プロジェクトはどのようなものなのか？
- 2022年から2032年にかけて、業界はどのように進化していくのか？また
現在および今後10年間に実施されるOTC医薬品・栄養補助食品プロジェクトの意味は？
- OTC医薬品・栄養補助食品市場をさらに拡大するために、製品の商業化の必要性は高いか？
- OTC医薬品・栄養補助食品市場の方向性と、市場の最前線に立つためにはどうすればよいか？
- 新製品・新サービスへの最適な投資方法とは？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

OTC医薬品・栄養補助食品市場に現在、そして今後10年間、どのような影響を与えるかを知る必要があります。
- 本レポートは400ページにわたり、167の表と224のグラフを掲載しています。
- 本レポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐターゲットにすることができます。
- 世界、地域、国別の売上高と成長率の詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、OTC医薬品・栄養補助食品市場が今後10年間にどのように発展し、COVID-19の景気後退と回復の変動に対応していくかを教えてくれるものです。この市場は、過去10年間のどの時点よりも今が重要なのです。

レポートでは、COVID-19のバリエーションや経済データなど、お客様の市場に特化した独自の情報をお届けしています。

2032年までの予測やその他の分析により、商業的な展望が見えてくる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場力学、ドライバー、機会、阻害要因など）、ポーターの5つの力分析、PEST分析、最近の動向などをご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

報告書の対象セグメント

カテゴリー別
- 咳止め
- 風邪薬・インフルエンザ薬
- 鎮痛剤
- 皮膚科領域
- ビタミン・ミネラル
- 減量剤・ダイエット剤
- 消化器官用薬
- アレルギー
- その他

剤形別
- 錠剤
- ハードカプセル
- 粉剤
- 軟膏
- ソフトカプセル
- 液剤
- その他

製品別
- ブランド薬
- ジェネリック薬

流通チャネル別
- 薬局・ドラッグストア
- スーパーマーケット/ハイパーマーケット
- コンビニエンスストア
- オンラインドラッグストア
- 健康食品店
- その他

世界市場全体とセグメントの収益予測に加え、5つの地域と34の主要国市場の収益予測も掲載しています。

北米
- 米国
- カナダ

欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ロシア
- ベルギー
- スイス
- オランダ
- その他の欧州

アジア太平洋
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- シンガポール
- タイ
- マレーシア
- インドネシア
- フィリピン
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- コロンビア
- アルゼンチン
- その他のラテンアメリカ地域

MEA
- 南アフリカ
- トルコ
- サウジアラビア
- UAE
- カタール
- その他のMEA地域

OTC医薬品・栄養補助食品市場の2022年から2032年にかけての主要企業のプロファイルと、これらの企業の事業のこのセグメントに焦点を当てた情報も含んでいます。

主要企業と市場成長の可能性
・ Abbott
・ Alcon
・ Alkem Labs
・ Bayer AG
・ Cipla Inc.
・ Dr. Reddy’s Laboratories Ltd.
・ F. Hoffmann-La Roche Ltd
・ Fresenius Medical Care AG ＆ Co. KGaA
・ Glanbia PLC
・ H. Lundbeck A/S
・ Haleon plc
・ Herbalife International of America, Inc.
・ Johnson ＆ Johnson Services, Inc.
・ Lupin
・ Nature’s Sunshine Products, Inc.
・ Nippon Chemiphar Co., Ltd.
・ Novartis AG
・ Perrigo Company plc
・ Pfizer Inc.
・ Reckitt Benckiser Group PLC
・ Sanofi
・ Sun Pharmaceutical Industries Ltd.
・ Taisho Pharmaceutical Holdings Co., Ltd.
・ Takeda Pharmaceutical Company Limited
・ Teva Pharmaceutical Industries Ltd.
・ Viatris Inc.

OTC医薬品・栄養補助食品市場の世界全体収益、2022年から2032年まで（金額ベース）は、2022年に2279億2000万米ドルを突破すると弊社は算出しています。また、2032年までの間に大幅な売上増を見込んでいます。弊社では、最も大きな可能性を秘めた組織を特定しています。彼らの能力、進歩、商業的展望を発見することで、一歩先を行くことができます。

OTC医薬品・栄養補助食品市場、2022年から2032年までのレポートはどのように役立つのでしょうか？
400ページに及ぶレポートでは、要約して以下のような知識を得ることができます。

-OTC医薬品・栄養補助食品市場の2032年までの収益予測、カテゴリー、剤形、製品、流通チャネル別に世界と地域レベルでそれぞれ予測 - 業界の展望、投資と収益に最も有利な場所を発見してください。

- 5地域と34主要国市場の2032年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAのOTC医薬品・栄養補助食品市場、2022年から2032年までの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなど、主要経済圏の市場も予測しています。

- 既存企業および市場参入を目指す企業の展望 - OTC医薬品・栄養補助食品市場に関わる主要企業26社の企業プロフィールを含む、2022年から2032年までの展望。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、OTC医薬品・栄養補助食品市場、2022年から2032年、市場の主要企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1.レポートの概要
1.1 調査の目的
1.2 OTC医薬品・栄養補助食品市場の紹介
1.3 本レポートの特徴
1.4 本レポートを読むべき理由
1.5 本分析報告書が回答する主な質問には以下が含まれます。
1.6 本レポートは誰のためのものなのか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場の推進要因
3.2.1.1 世界の医療制度におけるセルフケア
3.2.1.2 ダイエット運動の重要性が市場成長を牽引
3.2.2 市場抑制要因
3.2.2.1 Rx医薬品の集中が市場成長の妨げになる可能性
3.2.2.2 業界の成長を阻害する製造上の問題
3.2.3 市場機会
3.2.3.1 人口動態と経済の変化による成長機会の出現
3.2.3.2 新興国市場は活況を呈している
3.2.3.3 植物性サプリメントへのシフト
3.3 COVID-19の影響度分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤー・パワー
3.4.2 バイヤーパワー
3.4.3 競争相手との競合
3.4.4 代替品による脅威
3.4.5 新規参入者の脅威
3.5 PEST分析
3.5.1 政治的要因
3.5.2 経済的要因
3.5.3 社会的要因
3.5.4 技術的要因

4 OTC医薬品・栄養補助食品の産業構造
4.1 概要
4.2 OTC医薬品の要件
4.3 OTCスイッチング
4.3.1 処方薬をOTCに変更した場合
4.3.2 OTC医薬品の製造・販売
4.4 OTC医薬品の規制
4.4.1 米国
4.4.2 日本
4.4.3 欧州
4.4.4 その他の国々

5 OTC医薬品・栄養補助食品市場分析：カテゴリー別
5.1 主な調査結果
5.2 カテゴリー別の成長展望
5.3 OTC医薬品・栄養補助食品のカテゴリー別市場規模推定・予測
5.4 咳嗽薬、風邪薬、インフルエンザ薬
5.4.1 地域別市場予測、2022-2032 (10億米ドル)
5.4.2 地域別市場シェア、2022年＆2032年(%)
5.5 鎮痛剤
5.5.1 地域別市場予測、2022年〜2032年 (10億米ドル)
5.5.2 地域別市場シェア、2022年＆2032年(%)
5.6 皮膚科領域
5.6.1 地域別市場予測、2022年〜2032年 (10億米ドル)
5.6.2 地域別市場シェア、2022年＆2032年(%)
5.7 ビタミン・ミネラル
5.7.1 地域別市場予測、2022年〜2032年 (10億米ドル)
5.7.2 地域別市場シェア、2022年＆2032年(%)
5.8 ウェイトロス／ダイエット製品
5.8.1 地域別市場予測、2022年〜2032年(10億米ドル)
5.8.2 地域別市場シェア、2022年＆2032年(%)
5.9 消化器官用薬
5.9.1 地域別市場予測、2022年〜2032年 (10億米ドル)
5.9.2 地域別市場シェア、2022年＆2032年(%)
5.10 アレルギー剤
5.10.1 地域別市場予測、2022年〜2032年 (10億米ドル)
5.10.2 地域別市場シェア、2022年＆2032年(%)
5.11 その他
5.11.1 地域別市場予測、2022年〜2032年 (10億米ドル)
5.11.2 地域別市場シェア、2022年＆2032年(%)

6 OTC医薬品・栄養補助食品市場分析：剤形別
6.1 主な調査結果
6.2 ドサージフォームセグメントの成長展望
6.3 OTC医薬品・栄養補助食品の剤形別市場規模の推定と予測
6.4 錠剤
6.4.1 地域別市場予測、2022-2032 (億米ドル)
6.4.2 地域別市場シェア（2022年＆2032年）(%)
6.5 ハードカプセル
6.5.1 地域別市場予測、2022年～2032年 (10億米ドル)
6.5.2 地域別市場シェア、2022年＆2032年(%)
6.6 パウダー
6.6.1 地域別市場予測、2022年〜2032年 (10億米ドル)
6.6.2 地域別市場シェア、2022年＆2032年(%)
6.7 軟膏
6.7.1 地域別市場予測、2022年〜2032年 (10億米ドル)
6.7.2 地域別市場シェア、2022年＆2032年(%)
6.8 ソフトカプセル
6.8.1 地域別市場予測、2022年〜2032年 (10億米ドル)
6.8.2 地域別市場シェア、2022年＆2032年(%)
6.9 リキッド
6.9.1 地域別市場予測、2022年～2032年 (10億米ドル)
6.9.2 地域別市場シェア、2022年＆2032年(%)
6.10 その他
6.10.1 地域別市場予測、2022年〜2032年 (10億米ドル)
6.10.2 地域別市場シェア、2022年＆2032年(%)

7 OTC医薬品・栄養補助食品市場分析：製品タイプ
7.1 主な調査結果
7.2 製品タイプ別成長展望
7.3 OTC医薬品・栄養補助食品の製品タイプ別市場規模推定・予測
7.4 ブランド医薬品
7.4.1 地域別市場予測、2022年〜2032年（10億米ドル）
7.4.2 地域別市場シェア、2022年＆2032年(%)
7.5 ジェネリック医薬品
7.5.1 地域別市場予測、2022年〜2032年 (10億米ドル)
7.5.2 地域別市場シェア、2022年＆2032年(%)

8 OTC医薬品・栄養補助食品市場分析：：流通チャネル別
8.1 主な調査結果
8.2 流通チャネル別成長展望
8.3 OTC医薬品・栄養補助食品流通チャネル別市場規模予測・予測
8.4 薬局・ドラッグストア
8.4.1 地域別市場予測、2022年〜2032年（10億米ドル）
8.4.2 地域別市場シェア（2022年＆2032年）(%)
8.5 スーパーマーケット／ハイパーマーケット
8.5.1 地域別市場予測、2022年～2032年 (10億米ドル)
8.5.2 地域別市場シェア、2022年＆2032年(%)
8.6 コンビニエンスストア
8.6.1 地域別市場予測、2022年～2032年 (10億米ドル)
8.6.2 地域別市場シェア、2022年＆2032年(%)
8.7 オンラインドラッグストア
8.7.1 地域別市場予測、2022年～2032年 (10億米ドル)
8.7.2 地域別市場シェア、2022年＆2032年(%)
8.8 健康食品店
8.8.1 地域別市場予測、2022年〜2032年 (10億米ドル)
8.8.2 地域別市場シェア、2022年＆2032年(%)
8.9 その他
8.9.1 地域別市場予測、2022年〜2032年 (10億米ドル)
8.9.2 地域別市場シェア、2022年＆2032年(%)

9 OTC医薬品・栄養補助食品市場分析：地域別
9.1 主要な調査結果
9.2 地域別市場規模の推定と予測

10 北米のOTC医薬品・栄養補助食品市場分析
10.1 主な調査結果
10.2 北米OTC医薬品・栄養補助食品市場の魅力度指数
10.3 国別市場規模、2022年、2027年、2032年 (10億米ドル)
10.4 国別市場規模推定・予測、2022年～2032年（10億米ドル）
10.5 カテゴリ別市場規模推定・予測、2022年〜2032年（10億米ドル）
10.6 投与形態別市場規模予測・予測、2022年～2032年 (10億米ドル)
10.7 製品タイプ別市場規模予測・予測、2022年〜2032年 (10億米ドル)
10.8 流通チャネル別市場規模推定・予測、2022年～2032年 (bn米ドル)
10.9 米国
10.10 カナダ

11 欧州のOTC 医薬品・栄養補助食品市場分析
11.1 主な調査結果
11.2 欧州OTC医薬品・栄養補助食品市場の魅力度指数
11.3 国別市場規模、2022年、2027年、2032年 (10億米ドル)
11.4 国別市場規模推計・予測、2022年～2032年（10億米ドル）
11.5 カテゴリ別市場規模推定・予測、2022年〜2032年（10億米ドル）
11.6 投与形態別市場規模予測・予測、2022年〜2032年（10億米ドル）
11.7 製品タイプ別市場規模予測・予測、2022年〜2032年 (10億米ドル)
11.8 流通チャネル別市場規模推定・予測、2022年～2032年 (bn米ドル)
11.9 ドイツ
11.10 イギリス
11.11 フランス
11.12 イタリア
11.13 スペイン
11.14 ロシア
11.15 ベルギー
11.16 スイス
11.17 オランダ
11.18 その他の欧州

12 アジア太平洋地域のOTC医薬品・栄養補助食品市場分析
12.1 主な調査結果
12.2 アジア太平洋地域のOTC医薬品・栄養補助食品市場の魅力度指数
12.3 国別市場規模、2022年、2027年、2032年 (10億米ドル)
12.4 国別市場規模推定・予測、2022年～2032年（10億米ドル）
12.5 カテゴリ別市場規模推定・予測、2022年〜2032年（10億米ドル）
12.6 投与形態別市場規模予測・予測、2022年～2032年 (10億米ドル)
12.7 製品タイプ別市場規模予測・予測、2022年〜2032年 (10億米ドル)
12.8 流通チャネル別市場規模推定・予測、2022年～2032年 (10億米ドル)
12.9 日本
12.10 中国
12.11 インド
12.12 韓国
12.13 オーストラリア
12.14 シンガポール
12.15 タイ
12.16 マレーシア
12.17 インドネシア
12.18 フィリピン
12.19 その他のアジア太平洋地域

13 中南米のOTC医薬品・栄養補助食品市場分析
13.1 主な調査結果
13.2 ラテンアメリカのOTC医薬品・栄養補助食品市場の魅力度指数
13.3 国別市場規模、2022年、2027年、2032年 (10億米ドル)
13.4 国別市場規模推計・予測、2022年～2032年（10億米ドル）
13.5 カテゴリ別市場規模推定・予測、2022年〜2032年（10億米ドル）
13.6 投与形態別市場規模予測・予測、2022年～2032年 (10億米ドル)
13.7 製品タイプ別市場規模予測・予測、2022年〜2032年 (10億米ドル)
13.8 流通チャネル別市場規模推定・予測、2022年～2032年（US$ bn)
13.9 ブラジル
13.10 メキシコ
13.11 アルゼンチン
13.12 コロンビア
13.13 その他のラテンアメリカ地域

14 MEAのOTC医薬品・栄養補助食品市場分析
14.1 主な調査結果
14.2 MEAOTC医薬品・栄養補助食品市場魅力度指数
14.3 国別市場規模、2022年、2027年、2032年 (10億米ドル)
14.4 国別市場規模推定・予測、2022年～2032年（10億米ドル）
14.5 カテゴリ別市場規模推定・予測、2022年〜2032年（10億米ドル）
14.6 投与形態別市場規模予測・予測、2022年〜2032年（10億米ドル）
14.7 製品タイプ別市場規模予測・予測、2022年〜2032年（10億米ドル）
14.8 流通チャネル別市場規模推定・予測、2022年～2032年 (bn米ドル)
14.9 南アフリカ
14.10 トルコ
14.11 サウジアラビア
14.12 UAE
14.13 カタール
14.14 その他のMEA

15 主要企業のプロフィール
15.1 ジョンソン・エンド・ジョンソンサービス
15.1.1 企業スナップショット
15.1.2 会社概要
15.1.3 財務分析
15.1.3.1 純収益、2017年～2021年
15.1.3.2 売上総利益、2017年～2021年
15.1.3.3 R＆D、2017-2021年
15.1.4 製品ベンチマーク
15.1.5 戦略的な展望
15.2 ハレオン・ピーエルシー
15.2.1 企業スナップショット
15.2.2 会社概要
15.2.3 ベンチマーキング
15.2.4 戦略的展望
15.3 サノフィ
15.3.1 企業スナップショット
15.3.2 会社概要
15.3.3 財務分析
15.3.3.1 純収益、2017-2021年
15.3.3.2 売上総利益、2017年-2021年
15.3.3.3 R＆D、2017年～2021年
15.3.4 製品ベンチマーク
15.3.5 戦略的な展望
15.4 レキットベンキーザーグループPLC
15.4.1 企業スナップショット
15.4.2 会社概要
15.4.3 財務分析
15.4.3.1 純収益、2017年-2021年
15.4.3.2 売上総利益、2017年-2021年
15.4.4 製品ベンチマーク
15.4.5 戦略的な展望
15.5 バイエルAG
15.5.1 企業スナップショット
15.5.2 会社概要
15.5.3 財務分析
15.5.3.1 純収益、2017年-2021年
15.5.3.2 売上総利益、2017年-2021年
15.5.3.3 R＆D、2017-2021年
15.5.4 製品ベンチマーク
15.5.5 戦略的な展望
15.6 ペリゴ・カンパニー・ピーエルシー
15.6.1 企業スナップショット
15.6.2 会社概要
15.6.3 財務分析
15.6.3.1 純収益、2017年-2021年
15.6.3.2 売上総利益、2017年-2021年
15.6.3.3 R＆D、2017年-2021年
15.6.4 製品ベンチマーク
15.6.5 戦略的な展望
15.7 ヴィアトリス社
15.7.1 企業スナップショット
15.7.2 会社概要
15.7.3 財務分析
15.7.3.1 純収益、2017年-2021年
15.7.3.2 売上総利益、2017年-2021年
15.7.3.3 R＆D、2017年-2021年
15.7.4 製品ベンチマーク
15.7.5 戦略的展望
15.8 武田薬品工業株式会社
15.8.1 企業スナップショット
15.8.2 会社概要
15.8.3 財務分析
15.8.3.1 純収益、2017年-2021年
15.8.3.2 売上総利益、2017年-2021年
15.8.3.3 R＆D、2017年-2021年
15.8.4 製品ベンチマーク
15.8.5 戦略的な展望
15.9 大正製薬ホールディングス
15.9.1 企業スナップショット
15.9.2 会社概要
15.9.3 財務分析
15.9.3.1 純収益、2017-2021年
15.9.3.2 R＆D、2017年-2021年
15.9.4 製品ベンチマーク
15.9.5 戦略的な展望
15.10 日本ケミファ株式会社
15.10.1 企業スナップショット
15.10.2 会社概要
15.10.3 財務分析
15.10.3.1 純収益、2017-2021年
15.10.3.2 R＆D、2017年-2021年
15.10.4 製品ベンチマーク
15.10.5 戦略的な展望
15.11 H. Lundbeck A/S
15.11.1 企業スナップショット
15.11.2 会社概要
15.11.3 財務分析
15.11.3.1 純収益、2017-2021年
15.11.3.2 R＆D、2017年-2021年
15.11.4 製品ベンチマーク
15.11.5 戦略的な展望
15.12 テバ・ファーマシューティカル・インダストリーズ
15.12.1 企業スナップショット
15.12.2 会社概要
15.12.3 財務分析
15.12.3.1 純収益、2017年-2021年
15.12.3.2 売上総利益、2017年-2021年
15.12.3.3 R＆D、2017年-2021年
15.12.4 製品ベンチマーク
15.12.5 戦略的な展望
15.13 ノバルティスAG
15.13.1 企業スナップショット
15.13.2 会社概要
15.13.3 財務分析
15.13.3.1 純収益、2017年-2021年
15.13.3.2 売上総利益、2017年-2021年
15.13.3.3 R＆D、2017年-2021年
15.13.4 製品ベンチマーク
15.13.5 戦略的な展望
15.14 ファイザー株式会社
15.14.1 企業スナップショット
15.14.2 会社概要
15.14.3 財務分析
15.14.3.1 純収益、2017年-2021年
15.14.3.2 売上総利益、2017年-2021年
15.14.3.3 R＆D、2017年-2021年
15.14.4 製品ベンチマーク
15.14.5 戦略的な展望
15.15 アボット
15.15.1 企業スナップショット
15.15.2 会社概要
15.15.3 財務分析
15.15.3.1 純収益、2017年-2021年
15.15.3.2 売上総利益、2017年-2021年
15.15.3.3 R＆D、2017-2021年
15.15.4 製品ベンチマーク
15.15.5 戦略的な展望
15.16 フレゼニウス・メディカル・ケアAG＆Co.KGaA
15.16.1 企業スナップショット
15.16.2 会社概要
15.16.3 財務分析
15.16.3.1 純収益、2017年-2021年
15.16.3.2 売上総利益、2017年-2021年
15.16.3.3 R＆D、2017年-2021年
15.16.4 製品ベンチマーク
15.16.5 戦略的な展望
15.17 サンファーマシューティカルインダストリー
15.17.1 企業スナップショット
15.17.2 会社概要
15.17.3 財務分析
15.17.3.1 純収益、2018-2021年
15.17.4 製品ベンチマーク
15.17.5 戦略的な展望
15.18 F. ホフマン・ラ・ロシュ社
15.18.1 企業スナップショット
15.18.2 会社概要
15.18.3 財務分析
15.18.3.1 純収益、2017年-2021年
15.18.3.2 売上総利益、2017年-2021年
15.18.3.3 R＆D、2017年-2021年
15.18.4 製品ベンチマーク
15.18.5 戦略的な展望
15.19 ルパン
15.19.1 企業スナップショット
15.19.2 会社概要
15.19.3 製品ベンチマーク
15.19.4 戦略的展望
15.20 アルコン
15.20.1 企業スナップショット
15.20.2 会社概要
15.20.3 財務分析
15.20.3.1 純収益、2017年-2021年
15.20.3.2 売上総利益、2017年-2021年
15.20.3.3 R＆D、2017年-2021年
15.20.4 製品ベンチマーク
15.20.5 戦略的な展望
15.21 ハーバライフ・インターナショナル・オブ・アメリカ, Inc.
15.21.1 企業スナップショット
15.21.2 会社概要
15.21.3 製品ベンチマーク
15.22 グランビアPLC
15.22.1 企業スナップショット
15.22.2 会社概要
15.22.3 財務分析
15.22.3.1 純収益、2017年-2021年
15.22.3.2 売上総利益、2017年-2021年
15.22.4 製品ベンチマーク
15.23 ネイチャーズ・サンシャイン・プロダクツ
15.23.1 企業スナップショット
15.23.2 会社概要
15.23.3 製品ベンチマーク
15.24 アルケムラボ
15.24.1 企業スナップショット
15.24.2 会社概要
15.24.3 財務分析
15.24.3.1 純収益、2017-2021年
15.24.4 製品ベンチマーク
15.24.5 戦略的な展望
15.25 シプラ社
15.25.1 企業スナップショット
15.25.2 会社概要
15.25.3 財務分析
15.25.3.1 純収益、2017-2021年
15.25.4 製品ベンチマーク
15.25.5 戦略的な展望
15.26 ドクター・レディーズ・ラボラトリーズ・リミテッド
15.26.1 企業スナップショット
15.26.2 会社概要
15.26.3 財務分析
15.26.3.1 純収益、2017年-2021年
15.26.3.2 売上総利益、2017年-2021年
15.26.3.3 R＆D、2017年-2021年
15.26.4 製品ベンチマーク
15.26.5 戦略的展望

16 結論と提言
16.1 ヴィジョンゲインからの結論
16.2 市場関係者への提言

表の一覧
Table 1 OTC Drugs & Dietary Supplements Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “V” Shaped Recovery
Table 3 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “U” Shaped Recovery
Table 4 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “W” Shaped Recovery
Table 5 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “L” Shaped Recovery
Table 6 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 7 Cough, Cold and Flu Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 8 Analgesics Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 9 Dermatological Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Vitamins and Minerals Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 11 Weight Loss/Diet Products Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 12 Gastrointestinal Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 13 Allergy Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 16 Tablets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 17 Hard Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 18 Powders Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 19 Ointments Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 20 Soft Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 21 Liquids Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 23 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 24 Branded Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 25 Generic Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 26 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 27 Pharmacies/Drugstores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 28 Supermarkets/Hypermarkets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 29 Convenience Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 30 Online Drug Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Health Food Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 32 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 33 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 34 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 35 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 37 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 38 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 39 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 40 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 42 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 43 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 44 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 45 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 46 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 47 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 48 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 49 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 50 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 52 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 53 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 54 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 55 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 56 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 57 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 58 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 59 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 60 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 61 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 62 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 63 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 64 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 65 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 66 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 67 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 68 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 69 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 70 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 72 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 73 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 74 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 75 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 76 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 78 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 79 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 80 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 81 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 82 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 83 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 84 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 85 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 86 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 87 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 88 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 89 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 90 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 91 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 Rest of MEA Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 93 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 95 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 96 Haleon plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Haleon plc: Product Benchmarking
Table 98 Haleon plc: Strategic Outlook
Table 99 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Sanofi: Product Benchmarking
Table 101 Sanofi: Strategic Outlook
Table 102 Reckitt Benckiser Group PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Reckitt Benckiser Group PLC: Product Benchmarking
Table 104 Reckitt Benckiser Group PLC: Strategic Outlook
Table 105 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Bayer AG: Product Benchmarking
Table 107 Bayer AG: Strategic Outlook
Table 108 Perrigo Company plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Perrigo Company plc: Product Benchmarking
Table 110 Perrigo Company plc: Strategic Outlook
Table 111 Viatris Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Viatris Inc.: Product Benchmarking
Table 113 Viatris Inc.: Strategic Outlook
Table 114 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 116 Takeda Pharmaceutical Company Limited: Strategic Outlook
Table 117 Taisho Pharmaceutical Holdings Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Taisho Pharmaceutical Holdings Co., Ltd.: Product Benchmarking
Table 119 Taisho Pharmaceutical Holdings Co., Ltd.: Strategic Outlook
Table 120 Nippon Chemiphar Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Nippon Chemiphar Co., Ltd.: Product Benchmarking
Table 122 Nippon Chemiphar Co., Ltd.: Strategic Outlook
Table 123 H. Lundbeck A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 H. Lundbeck A/S: Product Benchmarking
Table 125 H. Lundbeck A/S: Strategic Outlook
Table 126 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 128 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 129 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Novartis AG: Product Benchmarking
Table 131 Novartis AG: Strategic Outlook
Table 132 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Pfizer Inc.: Product Benchmarking
Table 134 Pfizer Inc.: Strategic Outlook
Table 135 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Abbott: Product Benchmarking
Table 137 Abbott: Strategic Outlook
Table 138 Fresenius Medical Care AG & Co. KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Fresenius Medical Care AG & Co. KGaA: Product Benchmarking
Table 140 Fresenius Medical Care AG & Co. KGaA: Strategic Outlook
Table 141 Sun Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 Sun Pharmaceutical Industries Ltd.: Product Benchmarking
Table 143 Sun Pharmaceutical Industries Ltd.: Strategic Outlook
Table 144 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 146 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 147 Lupin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Lupin: Product Benchmarking
Table 149 Lupin: Strategic Outlook
Table 150 Alcon: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 Alcon: Product Benchmarking
Table 152 Alcon: Strategic Outlook
Table 153 Herbalife International of America, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Herbalife International of America, Inc.: Product Benchmarking
Table 155 Glanbia PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Glanbia PLC: Product Benchmarking
Table 157 Nature’s Sunshine Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Nature’s Sunshine Products, Inc.: Product Benchmarking
Table 159 Alkem Labs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 Alkem Labs: Product Benchmarking
Table 161 Alkem Labs: Strategic Outlook
Table 162 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Cipla Inc.: Product Benchmarking
Table 164 Cipla Inc.: Strategic Outlook
Table 165 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 167 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook

図の一覧
Figure 1 OTC Drugs & Dietary Supplements Market Segmentation
Figure 2 OTC Drugs & Dietary Supplements Market by Category: Market Attractiveness Index
Figure 3 OTC Drugs & Dietary Supplements Market by Dosage Form: Market Attractiveness Index
Figure 4 OTC Drugs & Dietary Supplements Market by Product Type: Market Attractiveness Index
Figure 5 OTC Drugs & Dietary Supplements Market by Distribution Channel: Market Attractiveness Index
Figure 6 OTC Drugs & Dietary Supplements Market Attractiveness Index by Region
Figure 7 OTC Drugs & Dietary Supplements Market: Market Dynamics
Figure 8 COVID Impact Analysis: OTC Drugs & Dietary Supplements Market Recovery Scenarios
Figure 9 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “V” Shaped Recovery
Figure 10 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “U” Shaped Recovery
Figure 11 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “W” Shaped Recovery
Figure 12 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “L” Shaped Recovery
Figure 13 OTC Drugs & Dietary Supplements Market: Porter’s Five Forces Analysis
Figure 14 OTC Pharmaceutical Supply Chain
Figure 15 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 16 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 17 OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022, 2027, 2032 (%)
Figure 18 Cough, Cold and Flu Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 19 Cough, Cold and Flu Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Analgesics Market Forecast by Region, 2022-2032 (US$ billion)
Figure 21 Analgesics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Dermatological Market Forecast by Region, 2022-2032 (US$ billion)
Figure 23 Dermatological Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Vitamins and Minerals Market Forecast by Region, 2022-2032 (US$ billion)
Figure 25 Vitamins and Minerals Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Weight Loss/Diet Products Market Forecast by Region, 2022-2032 (US$ billion)
Figure 27 Weight Loss/Diet Products Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Gastrointestinal Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 29 Gastrointestinal Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 30 Allergy Market Forecast by Region, 2022-2032 (US$ billion)
Figure 31 Allergy Market Share Forecast by Region, 2022 & 2032 (%)
Figure 32 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 33 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 34 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 35 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 36 OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022, 2027, 2032 (%)
Figure 37 Tablets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 38 Tablets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Hard Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 40 Hard Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Powders Market Forecast by Region, 2022-2032 (US$ billion)
Figure 42 Powders Market Share Forecast by Region, 2022 & 2032 (%)
Figure 43 Ointments Market Forecast by Region, 2022-2032 (US$ billion)
Figure 44 Ointments Market Share Forecast by Region, 2022 & 2032 (%)
Figure 45 Soft Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 46 Soft Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 47 Liquids Market Forecast by Region, 2022-2032 (US$ billion)
Figure 48 Liquids Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 50 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 OTC Drugs & Dietary Supplements Market Attractiveness Index by Product Type
Figure 52 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 53 OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022, 2027, 2032 (%)
Figure 54 Branded Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 55 Branded Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 56 Generic Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 57 Generic Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 58 OTC Drugs & Dietary Supplements Market Attractiveness Index by Distribution Channel
Figure 59 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 60 OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022, 2027, 2032 (%)
Figure 61 Pharmacies/Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 62 Pharmacies/Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 63 Supermarkets/Hypermarkets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 64 Supermarkets/Hypermarkets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 65 Convenience Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 66 Convenience Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 67 Online Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 68 Online Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 69 Health Food Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 70 Health Food Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 71 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 72 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 73 OTC Drugs & Dietary Supplements Market Forecast by Region 2022 & 2032 (Revenue, CAGR%)
Figure 74 OTC Drugs & Dietary Supplements Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 75 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn)
Figure 76 North America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 77 North America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 78 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 79 North America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 80 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 81 North America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 82 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 83 North America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 84 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 85 North America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 86 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 87 North America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 88 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 89 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 90 Europe OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 91 Europe OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 92 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 93 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 94 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 95 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 96 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 97 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 98 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 99 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 100 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 101 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 102 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 103 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 104 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 105 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 106 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 107 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 108 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 109 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 110 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 111 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 112 Asia Pacific OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 113 Asia Pacific OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 114 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 115 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 116 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 117 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 118 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 119 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 120 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 121 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 122 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 123 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 124 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 125 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 126 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 127 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 128 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 129 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 130 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 131 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 132 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 133 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 134 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 135 Latin America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 136 Latin America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 137 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 138 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 139 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 140 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 141 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 142 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 143 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 144 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 145 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 146 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 147 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 148 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 149 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 150 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 151 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 152 MEA OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 153 MEA OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 154 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 155 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 156 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 157 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 158 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 159 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 160 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 161 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 162 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 163 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 164 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 165 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 166 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 167 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 168 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 169 Rest of MEA OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 170 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 171 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 172 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 173 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 174 Sanofi: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 175 Sanofi: R&D, 2017-2021 (US$ million, AGR%)
Figure 176 Reckitt Benckiser Group PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 177 Reckitt Benckiser Group PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 178 Bayer AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 179 Bayer AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 180 Bayer AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 181 Perrigo Company plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 182 Perrigo Company plc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 183 Perrigo Company plc: R&D, 2017-2021 (US$ million, AGR%)
Figure 184 Viatris Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 185 Viatris Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 186 Viatris Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 187 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Takeda Pharmaceutical Company Limited: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 189 Takeda Pharmaceutical Company Limited: R&D, 2017-2021 (US$ million, AGR%)
Figure 190 Taisho Pharmaceutical Holdings Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 191 Taisho Pharmaceutical Holdings Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 192 Nippon Chemiphar Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 193 Nippon Chemiphar Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 194 H. Lundbeck A/S: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 195 H. Lundbeck A/S: R&D, 2017-2021 (US$ million, AGR%)
Figure 196 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 197 Teva Pharmaceutical Industries Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 198 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 199 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 200 Novartis AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 201 Novartis AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 202 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 203 Pfizer Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 204 Pfizer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 205 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 206 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 207 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 208 Fresenius Medical Care AG & Co. KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 209 Fresenius Medical Care AG & Co. KGaA: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 210 Fresenius Medical Care AG & Co. KGaA: R&D, 2017-2021 (US$ million, AGR%)
Figure 211 Sun Pharmaceutical Industries Ltd.: Net Revenue, 2018-2021 (US$ million, AGR%)
Figure 212 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 213 F. Hoffmann-La Roche Ltd: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 214 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
Figure 215 Alcon: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 216 Alcon: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 217 Alcon: R&D, 2017-2021 (US$ million, AGR%)
Figure 218 Glanbia PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 219 Glanbia PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 220 Alkem Labs: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 221 Cipla Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 222 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 223 Dr. Reddy’s Laboratories Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 224 Dr. Reddy’s Laboratories Ltd.: R&D, 2017-2021 (US$ million, AGR%)

ページTOPに戻る

Table of Contents

Summary

この調査レポートは世界のOTC医薬品・栄養補助食品市場を調査し、カテゴリー別、剤形別、製品別、流通チャネル別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容（目次より抜粋）

レポート概要
エグゼクティブサマリー
市場概要
OTC医薬品・栄養補助食品の業界構造
OTC医薬品・栄養補助食品市場分析：カテゴリー別
OTC医薬品・栄養補助食品市場分析：剤形別
OTC医薬品・栄養補助食品市場分析：製品タイプ別
OTC医薬品・栄養補助食品市場分析：流通チャネル別
OTC医薬品・栄養補助食品市場分析：地域別
北米のOTC医薬品・栄養補助食品市場分析
欧州のOTC医薬品・栄養補助食品市場分析
アジア太平洋地域のOTC医薬品・栄養補助食品市場分析
ラテンアメリカのOTC医薬品・栄養補助食品市場分析
MEAのOTC医薬品・栄養補助食品市場分析
主要企業のプロフィール

Report Details

The OTC Drugs & Dietary Supplements Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Self-Care Driving Market Growth
People in emerging and industrialized countries are now aware of their health, fitness and wellness programs, and this trend is growing worldwide. Immunization and vaccination, precautionary steps to decrease mortality among children and raise children’s immunity, improved living standards in many countries, and nutritional supplements are major efforts that have been adopted globally to extend people’s life expectancy.

Self-care is defined as the treatment of diseases through self-diagnosis without the assistance of a physician. Body aches and pains, fever, cough, colds, allergies, acne and other skincare difficulties, oral and dental hygiene, and gastrointestinal disorders such as indigestion and acidity can all be treated quickly with a self-care approach. The scope of self-care has expanded over time, and it is now not confined to primary care, but also includes improving health and well-being to reduce the risk of disease.

Importance of Dietary Campaigns Anticipated to Fuel Market Growth
Public health agencies, enforcement agencies, associations, industry, and other groups should invest in educational programs which provide advice on picking food supplements of quality and describe potential risks of goods that are not self-assured in their identity or quality. Consumers should be made aware that independent verification procedures from third parties can help establish the representations of products and ingredients. Sensitizing campaigns should focus on the most sensitive or expected physiological impacts of low-quality foodstuffs in consumers’ segments (e.g. senior citizens, pregnant women, military people, etc.)

What Questions Should You Ask before Buying a Market Research Report?
• How is the OTC drugs & dietary supplements market evolving?
• What is driving and restraining the OTC drugs & dietary supplements market?
• How will each OTC drugs & dietary supplements submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each OTC drugs & dietary supplements submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading OTC drugs & dietary supplements markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the OTC drugs & dietary supplements projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of
OTC drugs & dietary supplements projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the OTC drugs & dietary supplements market?
• Where is the OTC drugs & dietary supplements market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the OTC drugs & dietary supplements market today, and over the next 10 years:
• Our 400-page report provides 167 tables and 224 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the OTC drugs & dietary supplements market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

The report delivers exclusive COVID-19 variations and economic data specific to your market.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Category
• Cough
• Cold and Flu Drugs
• Analgesics
• Dermatological
• Vitamins and Minerals
• Weight Loss/Diet Products
• Gastrointestinal Drugs
• Allergy
• Others

Dosage Form
• Tablets
• Hard Capsules
• Powders
• Ointments
• Soft Capsules
• Liquids
• Others

Product
• Branded Drugs
• Generic Drugs

Distribution Channel
• Pharmacies/Drugstores
• Supermarkets/Hypermarkets
• Convenience Stores
• Online Drugstores
• Health Food Stores
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 34 leading national markets:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Italy
• Spain
• Russia
• Belgium
• Switzerland
• The Netherlands
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Singapore
• Thailand
• Malaysia
• Indonesia
• Philippines
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Colombia
• Argentina
• Rest of Latin America

MEA
• South Africa
• Turkey
• Saudi Arabia
• UAE
• Qatar
• Rest of MEA

The report also includes profiles and for some of the leading companies in the OTC Drugs & Dietary Supplements Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott
• Alcon
• Alkem Labs
• Bayer AG
• Cipla Inc.
• Dr. Reddy’s Laboratories Ltd.
• F. Hoffmann-La Roche Ltd
• Fresenius Medical Care AG & Co. KGaA
• Glanbia PLC
• H. Lundbeck A/S
• Haleon plc
• Herbalife International of America, Inc.
• Johnson & Johnson Services, Inc.
• Lupin
• Nature’s Sunshine Products, Inc.
• Nippon Chemiphar Co., Ltd.
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group PLC
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Taisho Pharmaceutical Holdings Co., Ltd.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

Overall world revenue for OTC Drugs & Dietary Supplements Market, 2022 to 2032 in terms of value the market will surpass US$227.92 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the OTC Drugs & Dietary Supplements Market, 2022 to 2032 report help you?
In summary, our 400-page report provides you with the following knowledge:

• Revenue forecasts to 2032 for OTC Drugs & Dietary Supplements Market, 2022 to 2032 Market, with forecasts for category, dosage form, product, and distribution channel, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for five regional and 34 key national markets – See forecasts for the OTC Drugs & Dietary Supplements Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 26 of the major companies involved in the OTC Drugs & Dietary Supplements Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the OTC Drugs & Dietary Supplements Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to OTC Drugs & Dietary Supplements Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Self-Care in the Global Health System
3.2.1.2 Importance of Dietary Campaigns Driving Market Growth
3.2.2 Market Restraining Factors
3.2.2.1 Concentration of Rx Drugs Likely to Hamper Market Growth
3.2.2.2 Manufacturing Issues to Stifle Industry Growth
3.2.3 Market Opportunities
3.2.3.1 Growth Opportunities will Emerge as a Result of Demographic & Economic Changes
3.2.3.2 Emerging Markets Are Booming
3.2.3.3 Shift Towards Plant-based Supplements
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors
3.5.2 Economic Factors
3.5.3 Social Factors
3.5.4 Technological Factors

4 OTC Drugs & Dietary Supplements Industry Structure
4.1 Overview
4.2 Requirements for an OTC Pharmaceutical Drug
4.3 OTC Switching
4.3.1 A Prescription Medicine Switched To OTC
4.3.2 Manufacturing and Distribution of OTC Pharmaceuticals
4.4 Regulation of OTC Pharmaceuticals
4.4.1 U.S.
4.4.2 Japan
4.4.3 Europe
4.4.4 Other Countries

5 OTC Drugs & Dietary Supplements Market Analysis by Category
5.1 Key Findings
5.2 Category Segment Growth Prospects
5.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Category
5.4 Cough, Cold and Flu Drugs
5.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Analgesics
5.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 Dermatological
5.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.6.2 Market Share by Region, 2022 & 2032 (%)
5.7 Vitamins and Minerals
5.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.7.2 Market Share by Region, 2022 & 2032 (%)
5.8 Weight Loss/Diet Products
5.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.8.2 Market Share by Region, 2022 & 2032 (%)
5.9 Gastrointestinal Drugs
5.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.9.2 Market Share by Region, 2022 & 2032 (%)
5.10 Allergy
5.10.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.10.2 Market Share by Region, 2022 & 2032 (%)
5.11 Others
5.11.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.11.2 Market Share by Region, 2022 & 2032 (%)

6 OTC Drugs & Dietary Supplements Market Analysis by Dosage Form
6.1 Key Findings
6.2 Dosage Form Segment Growth Prospects
6.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Dosage Form
6.4 Tablets
6.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.5 Hard Capsules
6.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.5.2 Market Share by Region, 2022 & 2032 (%)
6.6 Powders
6.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.6.2 Market Share by Region, 2022 & 2032 (%)
6.7 Ointments
6.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.7.2 Market Share by Region, 2022 & 2032 (%)
6.8 Soft Capsules
6.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.8.2 Market Share by Region, 2022 & 2032 (%)
6.9 Liquids
6.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.9.2 Market Share by Region, 2022 & 2032 (%)
6.10 Others
6.10.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.10.2 Market Share by Region, 2022 & 2032 (%)

7 OTC Drugs & Dietary Supplements Market Analysis by Product Type
7.1 Key Findings
7.2 Product Type Segment Growth Prospects
7.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Product Type
7.4 Branded Drugs
7.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Generic Drugs
7.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
7.5.2 Market Share by Region, 2022 & 2032 (%)

8 OTC Drugs & Dietary Supplements Market Analysis by Distribution Channel
8.1 Key Findings
8.2 Distribution Channel Segment Growth Prospects
8.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Distribution Channel
8.4 Pharmacies/Drugstores
8.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.4.2 Market Share by Region, 2022 & 2032 (%)
8.5 Supermarkets/Hypermarkets
8.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.5.2 Market Share by Region, 2022 & 2032 (%)
8.6 Convenience Stores
8.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.6.2 Market Share by Region, 2022 & 2032 (%)
8.7 Online Drugstores
8.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.7.2 Market Share by Region, 2022 & 2032 (%)
8.8 Health Food Stores
8.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.8.2 Market Share by Region, 2022 & 2032 (%)
8.9 Others
8.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.9.2 Market Share by Region, 2022 & 2032 (%)

9 OTC Drugs & Dietary Supplements Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America OTC Drugs & Dietary Supplements Market Analysis
10.1 Key Findings
10.2 North America OTC Drugs & Dietary Supplements Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
10.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
10.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
10.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
10.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
10.9 U.S.
10.10 Canada

11 Europe OTC Drugs & Dietary Supplements Market Analysis
11.1 Key Findings
11.2 Europe OTC Drugs & Dietary Supplements Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
11.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
11.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
11.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
11.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
11.9 Germany
11.10 UK
11.11 France
11.12 Italy
11.13 Spain
11.14 Russia
11.15 Belgium
11.16 Switzerland
11.17 Netherlands
11.18 Rest of Europe

12 Asia Pacific OTC Drugs & Dietary Supplements Market Analysis
12.1 Key Findings
12.2 Asia Pacific OTC Drugs & Dietary Supplements Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
12.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
12.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
12.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
12.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
12.9 Japan
12.10 China
12.11 India
12.12 South Korea
12.13 Australia
12.14 Singapore
12.15 Thailand
12.16 Malaysia
12.17 Indonesia
12.18 Philippines
12.19 Rest of Asia Pacific

13 Latin America OTC Drugs & Dietary Supplements Market Analysis
13.1 Key Findings
13.2 Latin America OTC Drugs & Dietary Supplements Market Attractiveness Index
13.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
13.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
13.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
13.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
13.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
13.9 Brazil
13.10 Mexico
13.11 Argentina
13.12 Colombia
13.13 Rest of Latin America

14 MEA OTC Drugs & Dietary Supplements Market Analysis
14.1 Key Findings
14.2 MEA OTC Drugs & Dietary Supplements Market Attractiveness Index
14.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
14.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
14.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
14.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
14.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
14.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
14.9 South Africa
14.10 Turkey
14.11 Saudi Arabia
14.12 UAE
14.13 Qatar
14.14 Rest of MEA

15 Company Profiles
15.1 Johnson & Johnson Services, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.3.1 Net Revenue, 2017-2021
15.1.3.2 Gross Profit, 2017-2021
15.1.3.3 R&D, 2017-2021
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.2 Haleon plc
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Product Benchmarking
15.2.4 Strategic Outlook
15.3 Sanofi
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2021
15.3.3.2 Gross Profit, 2017-2021
15.3.3.3 R&D, 2017-2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Reckitt Benckiser Group PLC
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2021
15.4.3.2 Gross Profit, 2017-2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Bayer AG
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2017-2021
15.5.3.2 Gross Profit, 2017-2021
15.5.3.3 R&D, 2017-2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Perrigo Company plc
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2021
15.6.3.2 Gross Profit, 2017-2021
15.6.3.3 R&D, 2017-2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Viatris Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2021
15.7.3.2 Gross Profit, 2017-2021
15.7.3.3 R&D, 2017-2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Takeda Pharmaceutical Company Limited
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2021
15.8.3.2 Gross Profit, 2017-2021
15.8.3.3 R&D, 2017-2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Taisho Pharmaceutical Holdings Co., Ltd.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2017-2021
15.9.3.2 R&D, 2017-2021
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Nippon Chemiphar Co., Ltd.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2021
15.10.3.2 R&D, 2017-2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 H. Lundbeck A/S
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2021
15.11.3.2 R&D, 2017-2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Teva Pharmaceutical Industries Ltd.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2017-2021
15.12.3.2 Gross Profit, 2017-2021
15.12.3.3 R&D, 2017-2021
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Novartis AG
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2017-2021
15.13.3.2 Gross Profit, 2017-2021
15.13.3.3 R&D, 2017-2021
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Pfizer Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2017-2021
15.14.3.2 Gross Profit, 2017-2021
15.14.3.3 R&D, 2017-2021
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Abbott
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2017-2021
15.15.3.2 Gross Profit, 2017-2021
15.15.3.3 R&D, 2017-2021
15.15.4 Product Benchmarking
15.15.5 Strategic Outlook
15.16 Fresenius Medical Care AG & Co. KGaA
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2017-2021
15.16.3.2 Gross Profit, 2017-2021
15.16.3.3 R&D, 2017-2021
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 Sun Pharmaceutical Industries Ltd.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2018-2021
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
15.18 F. Hoffmann-La Roche Ltd
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2017-2021
15.18.3.2 Gross Profit, 2017-2021
15.18.3.3 R&D, 2017-2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook
15.19 Lupin
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Product Benchmarking
15.19.4 Strategic Outlook
15.20 Alcon
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Financial Analysis
15.20.3.1 Net Revenue, 2017-2021
15.20.3.2 Gross Profit, 2017-2021
15.20.3.3 R&D, 2017-2021
15.20.4 Product Benchmarking
15.20.5 Strategic Outlook
15.21 Herbalife International of America, Inc.
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Product Benchmarking
15.22 Glanbia PLC
15.22.1 Company Snapshot
15.22.2 Company Overview
15.22.3 Financial Analysis
15.22.3.1 Net Revenue, 2017-2021
15.22.3.2 Gross Profit, 2017-2021
15.22.4 Product Benchmarking
15.23 Nature’s Sunshine Products, Inc.
15.23.1 Company Snapshot
15.23.2 Company Overview
15.23.3 Product Benchmarking
15.24 Alkem Labs
15.24.1 Company Snapshot
15.24.2 Company Overview
15.24.3 Financial Analysis
15.24.3.1 Net Revenue, 2017-2021
15.24.4 Product Benchmarking
15.24.5 Strategic Outlook
15.25 Cipla Inc.
15.25.1 Company Snapshot
15.25.2 Company Overview
15.25.3 Financial Analysis
15.25.3.1 Net Revenue, 2017-2021
15.25.4 Product Benchmarking
15.25.5 Strategic Outlook
15.26 Dr. Reddy’s Laboratories Ltd.
15.26.1 Company Snapshot
15.26.2 Company Overview
15.26.3 Financial Analysis
15.26.3.1 Net Revenue, 2017-2021
15.26.3.2 Gross Profit, 2017-2021
15.26.3.3 R&D, 2017-2021
15.26.4 Product Benchmarking
15.26.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 OTC Drugs & Dietary Supplements Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “V” Shaped Recovery
Table 3 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “U” Shaped Recovery
Table 4 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “W” Shaped Recovery
Table 5 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “L” Shaped Recovery
Table 6 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 7 Cough, Cold and Flu Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 8 Analgesics Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 9 Dermatological Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Vitamins and Minerals Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 11 Weight Loss/Diet Products Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 12 Gastrointestinal Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 13 Allergy Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 16 Tablets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 17 Hard Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 18 Powders Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 19 Ointments Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 20 Soft Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 21 Liquids Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 23 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 24 Branded Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 25 Generic Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 26 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 27 Pharmacies/Drugstores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 28 Supermarkets/Hypermarkets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 29 Convenience Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 30 Online Drug Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Health Food Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 32 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 33 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 34 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 35 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 37 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 38 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 39 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 40 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 42 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 43 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 44 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 45 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 46 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 47 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 48 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 49 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 50 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 52 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 53 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 54 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 55 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 56 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 57 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 58 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 59 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 60 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 61 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 62 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 63 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 64 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 65 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 66 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 67 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 68 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 69 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 70 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 72 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 73 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 74 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 75 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 76 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 78 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 79 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 80 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 81 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 82 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 83 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 84 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 85 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 86 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 87 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 88 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 89 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 90 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 91 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 Rest of MEA Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 93 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 95 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 96 Haleon plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Haleon plc: Product Benchmarking
Table 98 Haleon plc: Strategic Outlook
Table 99 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Sanofi: Product Benchmarking
Table 101 Sanofi: Strategic Outlook
Table 102 Reckitt Benckiser Group PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Reckitt Benckiser Group PLC: Product Benchmarking
Table 104 Reckitt Benckiser Group PLC: Strategic Outlook
Table 105 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Bayer AG: Product Benchmarking
Table 107 Bayer AG: Strategic Outlook
Table 108 Perrigo Company plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Perrigo Company plc: Product Benchmarking
Table 110 Perrigo Company plc: Strategic Outlook
Table 111 Viatris Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Viatris Inc.: Product Benchmarking
Table 113 Viatris Inc.: Strategic Outlook
Table 114 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 116 Takeda Pharmaceutical Company Limited: Strategic Outlook
Table 117 Taisho Pharmaceutical Holdings Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Taisho Pharmaceutical Holdings Co., Ltd.: Product Benchmarking
Table 119 Taisho Pharmaceutical Holdings Co., Ltd.: Strategic Outlook
Table 120 Nippon Chemiphar Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Nippon Chemiphar Co., Ltd.: Product Benchmarking
Table 122 Nippon Chemiphar Co., Ltd.: Strategic Outlook
Table 123 H. Lundbeck A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 H. Lundbeck A/S: Product Benchmarking
Table 125 H. Lundbeck A/S: Strategic Outlook
Table 126 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 128 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 129 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Novartis AG: Product Benchmarking
Table 131 Novartis AG: Strategic Outlook
Table 132 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Pfizer Inc.: Product Benchmarking
Table 134 Pfizer Inc.: Strategic Outlook
Table 135 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Abbott: Product Benchmarking
Table 137 Abbott: Strategic Outlook
Table 138 Fresenius Medical Care AG & Co. KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Fresenius Medical Care AG & Co. KGaA: Product Benchmarking
Table 140 Fresenius Medical Care AG & Co. KGaA: Strategic Outlook
Table 141 Sun Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 Sun Pharmaceutical Industries Ltd.: Product Benchmarking
Table 143 Sun Pharmaceutical Industries Ltd.: Strategic Outlook
Table 144 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 146 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 147 Lupin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Lupin: Product Benchmarking
Table 149 Lupin: Strategic Outlook
Table 150 Alcon: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 Alcon: Product Benchmarking
Table 152 Alcon: Strategic Outlook
Table 153 Herbalife International of America, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Herbalife International of America, Inc.: Product Benchmarking
Table 155 Glanbia PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Glanbia PLC: Product Benchmarking
Table 157 Nature’s Sunshine Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Nature’s Sunshine Products, Inc.: Product Benchmarking
Table 159 Alkem Labs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 Alkem Labs: Product Benchmarking
Table 161 Alkem Labs: Strategic Outlook
Table 162 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Cipla Inc.: Product Benchmarking
Table 164 Cipla Inc.: Strategic Outlook
Table 165 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 167 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook

List of Figures
Figure 1 OTC Drugs & Dietary Supplements Market Segmentation
Figure 2 OTC Drugs & Dietary Supplements Market by Category: Market Attractiveness Index
Figure 3 OTC Drugs & Dietary Supplements Market by Dosage Form: Market Attractiveness Index
Figure 4 OTC Drugs & Dietary Supplements Market by Product Type: Market Attractiveness Index
Figure 5 OTC Drugs & Dietary Supplements Market by Distribution Channel: Market Attractiveness Index
Figure 6 OTC Drugs & Dietary Supplements Market Attractiveness Index by Region
Figure 7 OTC Drugs & Dietary Supplements Market: Market Dynamics
Figure 8 COVID Impact Analysis: OTC Drugs & Dietary Supplements Market Recovery Scenarios
Figure 9 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “V” Shaped Recovery
Figure 10 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “U” Shaped Recovery
Figure 11 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “W” Shaped Recovery
Figure 12 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “L” Shaped Recovery
Figure 13 OTC Drugs & Dietary Supplements Market: Porter’s Five Forces Analysis
Figure 14 OTC Pharmaceutical Supply Chain
Figure 15 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 16 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 17 OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022, 2027, 2032 (%)
Figure 18 Cough, Cold and Flu Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 19 Cough, Cold and Flu Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Analgesics Market Forecast by Region, 2022-2032 (US$ billion)
Figure 21 Analgesics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Dermatological Market Forecast by Region, 2022-2032 (US$ billion)
Figure 23 Dermatological Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Vitamins and Minerals Market Forecast by Region, 2022-2032 (US$ billion)
Figure 25 Vitamins and Minerals Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Weight Loss/Diet Products Market Forecast by Region, 2022-2032 (US$ billion)
Figure 27 Weight Loss/Diet Products Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Gastrointestinal Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 29 Gastrointestinal Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 30 Allergy Market Forecast by Region, 2022-2032 (US$ billion)
Figure 31 Allergy Market Share Forecast by Region, 2022 & 2032 (%)
Figure 32 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 33 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 34 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 35 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 36 OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022, 2027, 2032 (%)
Figure 37 Tablets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 38 Tablets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Hard Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 40 Hard Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Powders Market Forecast by Region, 2022-2032 (US$ billion)
Figure 42 Powders Market Share Forecast by Region, 2022 & 2032 (%)
Figure 43 Ointments Market Forecast by Region, 2022-2032 (US$ billion)
Figure 44 Ointments Market Share Forecast by Region, 2022 & 2032 (%)
Figure 45 Soft Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 46 Soft Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 47 Liquids Market Forecast by Region, 2022-2032 (US$ billion)
Figure 48 Liquids Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 50 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 OTC Drugs & Dietary Supplements Market Attractiveness Index by Product Type
Figure 52 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 53 OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022, 2027, 2032 (%)
Figure 54 Branded Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 55 Branded Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 56 Generic Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 57 Generic Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 58 OTC Drugs & Dietary Supplements Market Attractiveness Index by Distribution Channel
Figure 59 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 60 OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022, 2027, 2032 (%)
Figure 61 Pharmacies/Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 62 Pharmacies/Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 63 Supermarkets/Hypermarkets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 64 Supermarkets/Hypermarkets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 65 Convenience Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 66 Convenience Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 67 Online Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 68 Online Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 69 Health Food Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 70 Health Food Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 71 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 72 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 73 OTC Drugs & Dietary Supplements Market Forecast by Region 2022 & 2032 (Revenue, CAGR%)
Figure 74 OTC Drugs & Dietary Supplements Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 75 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn)
Figure 76 North America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 77 North America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 78 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 79 North America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 80 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 81 North America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 82 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 83 North America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 84 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 85 North America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 86 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 87 North America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 88 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 89 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 90 Europe OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 91 Europe OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 92 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 93 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 94 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 95 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 96 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 97 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 98 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 99 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 100 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 101 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 102 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 103 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 104 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 105 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 106 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 107 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 108 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 109 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 110 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 111 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 112 Asia Pacific OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 113 Asia Pacific OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 114 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 115 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 116 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 117 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 118 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 119 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 120 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 121 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 122 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 123 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 124 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 125 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 126 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 127 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 128 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 129 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 130 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 131 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 132 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 133 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 134 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 135 Latin America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 136 Latin America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 137 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 138 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 139 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 140 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 141 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 142 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 143 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 144 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 145 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 146 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 147 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 148 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 149 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 150 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 151 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 152 MEA OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 153 MEA OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 154 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 155 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 156 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 157 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 158 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 159 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 160 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 161 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 162 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 163 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 164 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 165 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 166 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 167 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 168 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 169 Rest of MEA OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 170 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 171 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 172 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 173 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 174 Sanofi: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 175 Sanofi: R&D, 2017-2021 (US$ million, AGR%)
Figure 176 Reckitt Benckiser Group PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 177 Reckitt Benckiser Group PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 178 Bayer AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 179 Bayer AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 180 Bayer AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 181 Perrigo Company plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 182 Perrigo Company plc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 183 Perrigo Company plc: R&D, 2017-2021 (US$ million, AGR%)
Figure 184 Viatris Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 185 Viatris Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 186 Viatris Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 187 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Takeda Pharmaceutical Company Limited: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 189 Takeda Pharmaceutical Company Limited: R&D, 2017-2021 (US$ million, AGR%)
Figure 190 Taisho Pharmaceutical Holdings Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 191 Taisho Pharmaceutical Holdings Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 192 Nippon Chemiphar Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 193 Nippon Chemiphar Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 194 H. Lundbeck A/S: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 195 H. Lundbeck A/S: R&D, 2017-2021 (US$ million, AGR%)
Figure 196 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 197 Teva Pharmaceutical Industries Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 198 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 199 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 200 Novartis AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 201 Novartis AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 202 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 203 Pfizer Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 204 Pfizer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 205 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 206 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 207 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 208 Fresenius Medical Care AG & Co. KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 209 Fresenius Medical Care AG & Co. KGaA: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 210 Fresenius Medical Care AG & Co. KGaA: R&D, 2017-2021 (US$ million, AGR%)
Figure 211 Sun Pharmaceutical Industries Ltd.: Net Revenue, 2018-2021 (US$ million, AGR%)
Figure 212 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 213 F. Hoffmann-La Roche Ltd: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 214 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
Figure 215 Alcon: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 216 Alcon: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 217 Alcon: R&D, 2017-2021 (US$ million, AGR%)
Figure 218 Glanbia PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 219 Glanbia PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 220 Alkem Labs: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 221 Cipla Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 222 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 223 Dr. Reddy’s Laboratories Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 224 Dr. Reddy’s Laboratories Ltd.: R&D, 2017-2021 (US$ million, AGR%)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（dietary）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。